Key facts
- This page summarizes Micki Klearman's Form 4 filing for Kezar Life Sciences, Inc. (KZR).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 23 Jun 2025, 17:00.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
One-hundred percent (100%) of the shares subject to the option shall vest on 6/18/2026, subject to Reporting Person continuing to provide service through such date.